What are the recommended radiological investigations for insulinoma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Radiological Investigations for Insulinoma

For patients with suspected insulinoma, a multimodal imaging approach is recommended with endoscopic ultrasound (EUS) as the preferred initial localization method due to its high sensitivity of 82-93% for detecting pancreatic neuroendocrine tumors. 1, 2

First-Line Imaging Modalities

  • Endoscopic Ultrasound (EUS): Highly sensitive (82-93%) for detecting small pancreatic tumors and is particularly valuable for obtaining tissue samples and determining surgical approach (enucleation vs. Whipple procedure) 1, 2

  • Multiphasic CT: Sensitivity of 57-94% for pancreatic NETs, should be performed with arterial and venous phase imaging as insulinomas typically appear hypervascular in the arterial phase with a mean enhancement of 147 HU 1, 3

  • MRI: Sensitivity of 74-94% for pancreatic NETs; insulinomas typically appear hypointense on T1-weighted sequences and isointense to slightly hyperintense on T2-weighted sequences 1, 3

Second-Line Imaging Modalities

  • Intra-arterial calcium stimulation with hepatic venous sampling (Imamura-Doppman procedure): Particularly valuable for occult insulinomas with success rates up to 90% in localization when first-line imaging is inconclusive 1, 2

  • Somatostatin Receptor Scintigraphy (SSRS): Limited sensitivity (50-60%) specifically for insulinomas compared to other pancreatic NETs, but may be useful when other imaging is inconclusive 1

  • 68Ga-DOTATOC PET: Higher sensitivity (87-96%) than conventional SSRS for pancreatic NETs, though specific sensitivity for insulinomas may vary 1

Intraoperative Imaging

  • Intraoperative Ultrasound (IOUS): Excellent adjunct to surgical palpation with ability to identify small lesions in the pancreatic head and multiple lesions (92-97% sensitivity in MEN1 syndrome); also allows assessment of the liver 1, 4

Imaging Algorithm

  1. Start with non-invasive cross-sectional imaging:

    • Multiphasic CT (arterial and venous phases) AND/OR
    • MRI with contrast enhancement 1, 3
  2. If initial imaging is negative or inconclusive:

    • Proceed to EUS (which also allows for tissue sampling) 2, 5
  3. For difficult-to-localize cases:

    • Consider intra-arterial calcium stimulation with hepatic venous sampling 1, 2
    • Consider nuclear medicine imaging (68Ga-DOTATOC PET preferred over conventional SSRS) 1
  4. Plan for intraoperative ultrasound during surgery regardless of preoperative localization success 1, 4

Important Considerations

  • Insulinomas are typically small (66% <2cm at presentation), making them challenging to localize radiologically 6

  • The combination of biphasic thin-section helical CT and EUS approaches 100% sensitivity in localizing insulinomas 4

  • Laparoscopic ultrasound is considered mandatory for intraoperative localization of these tumors 4

  • For patients who cannot undergo EUS, the combination of high-quality CT and MRI provides the best non-invasive detection strategy 3

  • Accurate preoperative localization is crucial as complete surgical resection is the only curative treatment, with a success rate of 90% 2, 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic and Treatment Approach for Insulinoma

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Preoperative tumor studies using MRI or CT in patients with clinically suspected insulinoma.

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2011

Research

Pancreatic insulinoma: current issues and trends.

Hepatobiliary & pancreatic diseases international : HBPD INT, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.